X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (111) 111
Publication (13) 13
Conference Proceeding (3) 3
Book Chapter (2) 2
Patent (2) 2
Book / eBook (1) 1
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (61) 61
female (46) 46
oncology (44) 44
index medicus (41) 41
middle aged (39) 39
aged (36) 36
chemotherapy (33) 33
adult (31) 31
male (31) 31
antineoplastic combined chemotherapy protocols - therapeutic use (27) 27
cancer (22) 22
disease-free survival (20) 20
therapy (17) 17
clinical trials (16) 16
colorectal cancer (16) 16
survival (15) 15
fluorouracil - administration & dosage (14) 14
treatment outcome (14) 14
aged, 80 and over (13) 13
survival analysis (13) 13
breast cancer (12) 12
breast neoplasms - drug therapy (12) 12
care and treatment (12) 12
chemotherapy, adjuvant (12) 12
metastasis (12) 12
analysis (11) 11
drug administration schedule (11) 11
hematology, oncology and palliative medicine (11) 11
organoplatinum compounds - administration & dosage (11) 11
oxaliplatin (11) 11
fluorouracil (10) 10
medicine, general & internal (10) 10
neoplasm staging (10) 10
surgery (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (9) 9
colorectal neoplasms - drug therapy (9) 9
follow-up studies (9) 9
gemcitabine (9) 9
leucovorin (9) 9
quality of life (9) 9
antineoplastic agents - adverse effects (8) 8
antineoplastic agents - therapeutic use (8) 8
breast neoplasms - pathology (8) 8
cancer therapies (8) 8
colonic neoplasms - drug therapy (8) 8
research (8) 8
risk factors (8) 8
antineoplastic combined chemotherapy protocols - administration & dosage (7) 7
colorectal neoplasms - pathology (7) 7
leucovorin - administration & dosage (7) 7
paclitaxel (7) 7
antimitotic agents (6) 6
antineoplastic agents (6) 6
antineoplastic agents - administration & dosage (6) 6
clinical-trials (6) 6
colon cancer (6) 6
colonic neoplasms - pathology (6) 6
cyclophosphamide (6) 6
docetaxel (6) 6
epirubicin - administration & dosage (6) 6
kaplan-meier estimate (6) 6
medical and health sciences (6) 6
medicin och hälsovetenskap (6) 6
product development (6) 6
survival rate (6) 6
adenocarcinoma - drug therapy (5) 5
cetuximab (5) 5
clinical medicine (5) 5
colonic neoplasms - mortality (5) 5
deoxycytidine - administration & dosage (5) 5
deoxycytidine - analogs & derivatives (5) 5
disease progression (5) 5
fluorouracil - adverse effects (5) 5
hospitals (5) 5
infusions, intravenous (5) 5
klinisk medicin (5) 5
lymphatic metastasis (5) 5
medical research (5) 5
mortality (5) 5
neoadjuvant therapy (5) 5
open-label (5) 5
patients (5) 5
prognosis (5) 5
quality-of-life (5) 5
trastuzumab (5) 5
abridged index medicus (4) 4
adjuvant chemotherapy (4) 4
antibodies, monoclonal, humanized - administration & dosage (4) 4
bevacizumab (4) 4
cancer and oncology (4) 4
cancer och onkologi (4) 4
capecitabine (4) 4
colon-cancer (4) 4
colorectal carcinoma (4) 4
cyclophosphamide - administration & dosage (4) 4
drug therapy (4) 4
epidemiology (4) 4
expression (4) 4
fluorouracil - therapeutic use (4) 4
health aspects (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 6, pp. 601 - 611
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 829 - 840
Summary Background We aimed to assess the efficacy and safety of sequential or simultaneous telomerase vaccination (GV1001) in combination with chemotherapy in... 
Hematology, Oncology and Palliative Medicine | COLONY-STIMULATING FACTOR | ONCOLOGY | DUCTAL ADENOCARCINOMA | IMMUNOTHERAPY | METAANALYSES | SUPPRESSOR-CELLS | RESISTANT PROSTATE-CANCER | T-CELLS | CHEMOTHERAPY | IPILIMUMAB | TUMOR-ANTIGEN | Cell Proliferation | Capecitabine | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Fatigue - chemically induced | Pain - chemically induced | Pancreatic Neoplasms - drug therapy | Fluorouracil - administration & dosage | Female | Neutropenia - chemically induced | Granulocyte-Macrophage Colony-Stimulating Factor - administration & dosage | Fluorouracil - analogs & derivatives | Cancer Vaccines - administration & dosage | Deoxycytidine - administration & dosage | Pancreatic Ducts | Pancreatic Neoplasms - pathology | Peptide Fragments - administration & dosage | Immunologic Factors - administration & dosage | Kaplan-Meier Estimate | Cancer Vaccines - adverse effects | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Telomerase - administration & dosage | Disease-Free Survival | Telomerase - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | T-Lymphocytes - immunology | Aged | Peptide Fragments - adverse effects | Deoxycytidine - analogs & derivatives | Care and treatment | Chemotherapy | Hospitals | Gemcitabine | Peptides | Pancreatic cancer | Vaccination | Product development | Vaccines | Metastasis | Telomerase | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 6, pp. 656 - 666
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 7, pp. 642 - 653
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 2, pp. 201 - 212
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 4, pp. 486 - 499
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 6/2012, Volume 133, Issue 3, pp. 1057 - 1065
Journal Article